The novel and selective insulin-like growth factor-1 receptor kinase inhibitor pqip suppresses bone cell function and osteoclast-breast cancer cell cross-talk

被引：0
|
作者：
Logan, J. G. [1 ,2 ]
Sophocleous, A. [1 ]
Landao-Bassonga, E. [1 ]
Brunton, V. G. [2 ]
Idris, A. I. [1 ,2 ]
机构：
[1] Univ Edinburgh, Inst Genet & Mol Med, Ctr Mol Med, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland
来源：
BONE | 2011年 / 48卷
关键词：
D O I：
10.1016/j.bone.2011.03.631
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S257 / S257
页数：1
相关论文
共 50 条
  • [21] FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion
    Joanna Stanicka
    Leonie Rieger
    Sandra O’Shea
    Orla Cox
    Michael Coleman
    Ciara O’Flanagan
    Barbara Addario
    Nuala McCabe
    Richard Kennedy
    Rosemary O’Connor
    Oncogene, 2018, 37 : 3131 - 3150
  • [22] FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion
    Stanicka, Joanna
    Rieger, Leonie
    O'Shea, Sandra
    Cox, Orla
    Coleman, Michael
    O'Flanagan, Ciara
    Addario, Barbara
    McCabe, Nuala
    Kennedy, Richard
    O'Connor, Rosemary
    ONCOGENE, 2018, 37 (23) : 3131 - 3150
  • [23] Silencing insulin-like growth factor-1 receptor expression inhibits gastric cancer cell proliferation and invasion
    Ge, Jie
    Chen, Zihua
    Huang, Jin
    Yuan, Weijie
    Den, Zhenghao
    Chen, Zhikang
    MOLECULAR MEDICINE REPORTS, 2015, 11 (01) : 633 - 638
  • [24] Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase - Implication for inhibitor specificity
    Munshi, S
    Kornienko, M
    Hall, DL
    Reid, JC
    Waxman, L
    Stirdivant, SM
    Darke, PL
    Kuo, LC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 38797 - 38802
  • [25] A paradigm shift for insulin-like growth factor-1 receptor function in triple negative breast cancers
    Obr, A. E.
    Wood, T. L.
    CANCER RESEARCH, 2017, 77
  • [26] IMMUNOHISTOCHEMICAL EXPRESSION OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR IN SQUAMOUS CELL CARCINOMAS OF THE PENIS
    Ball, Mark
    Bezerra, Stephania
    Chaux, Alcides
    Faraj, Sheila
    Gonzalez-Roibon, Nilda
    Munari, Enrico
    Sharma, Rajni
    Netto, George
    Burnett, Arthur
    JOURNAL OF UROLOGY, 2014, 191 (04): : E120 - E120
  • [27] Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins
    Parrizas, M
    Gazit, A
    Levitzki, A
    Wertheimer, E
    LeRoith, D
    ENDOCRINOLOGY, 1997, 138 (04) : 1427 - 1433
  • [28] Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor
    Hu, Yi Peter
    Patil, Sandip B.
    Panasiewicz, Michelle
    Li, Wenhui
    Hauser, Jennie
    Humphrey, Lisa E.
    Brattain, Michael G.
    CANCER RESEARCH, 2008, 68 (19) : 8004 - 8013
  • [29] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Peled, Nir
    Wynes, Murry W.
    Ikeda, Norihiko
    Ohira, Tatsuo
    Yoshida, Koichi
    Qian, Jin
    Ilouze, Maya
    Brenner, Ronen
    Kato, Yasufumi
    Mascaux, Celine
    Hirsch, Fred R.
    CELLULAR ONCOLOGY, 2013, 36 (04) : 277 - 288
  • [30] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Nir Peled
    Murry W. Wynes
    Norihiko Ikeda
    Tatsuo Ohira
    Koichi Yoshida
    Jin Qian
    Maya Ilouze
    Ronen Brenner
    Yasufumi Kato
    Celine Mascaux
    Fred R. Hirsch
    Cellular Oncology, 2013, 36 : 277 - 288
12345